As GLP-1 RAs become increasingly prevalent, retina specialists play a critical role in ensuring that patients receive the systemic benefits of these agents while minimizing ocular risk through surveillance, education and collaboration
Who is a candidate, and who is not Inquire about preferred smoothness of recovery, four- to six-week daily self-injection capability and documented health history for tolerance
Clinical trial evidence from SURMOUNT-1 The landmark SURMOUNT-1 trial, published by Jastreboff and colleagues, provided some of the cleanest data on tirzepatide and hair loss
Dermal fillers are substances that are injected into the skin to add volume, fill in wrinkles or lines, and enhance facial contours
Restore comfortable, flexible movement with a clinically noticeably improvement in just 7 dayswith no rebound effect